← Eichor
Condition: Atherosclerotic Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Atherosclerotic Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
NA · 1 location(s) · Ryazan State Medical University · NCT05933720
Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs
NA · 1 location(s) · Shanghai Jiao Tong University Affiliated Sixth People's Hosp · NCT06754956
Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease
NA · 1 location(s) · Vestre Viken Hospital Trust · NCT06738381
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Phase N/A · 1 location(s) · Anhui Medical University · NCT06336174
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
NA · 18 location(s) · Harbin Medical University · NCT06365502
Fish Oil, Metformin and Heart Health in PCOS
Phase 1 · 3 location(s) · University of Alberta · NCT06424860
Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia
Phase 3 · 1 location(s) · Ottawa Heart Institute Research Corporation · NCT06710080
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Phase 4 · 19 location(s) · Peking Union Medical College Hospital · NCT06902740
STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femor
NA · 3 location(s) · Balton Sp.zo.o. · NCT06734221
TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure
Phase N/A · 1 location(s) · John Paul II Hospital, Krakow · NCT05250349
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820
Penn Medicine Healthy Heart
NA · 1 location(s) · University of Pennsylvania · NCT06062394
Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183
Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06226844
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT06767345
PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques
Phase N/A · 2 location(s) · Ruijin Hospital · NCT06794684
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic
NA · 1 location(s) · Rajaie Cardiovascular Medical and Research Center · NCT06541691
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Phase 2 · 1 location(s) · Wake Forest University Health Sciences · NCT06488105
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
NA · 3 location(s) · University of Aarhus · NCT05834803
A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Dis
Phase 3 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT07551492
Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke
NA · 1 location(s) · Beijing Anzhen Hospital · NCT07026318
A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Str
Phase N/A · 1 location(s) · Fujian Medical University Union Hospital · NCT06881420
CArdioMetabolism and Atherosclerotic PlaqUe progreSsion
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05117424
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events i
Phase N/A · 90 location(s) · Amgen · NCT06295679
LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05765370
Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus
Phase N/A · 2 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07237685
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD
NA · 2 location(s) · Sunnybrook Health Sciences Centre · NCT06714526
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
Phase N/A · 1 location(s) · jiaoliqun · NCT05550077
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · 40 location(s) · Amgen · NCT07293260
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.